Market Share of Global Diagnostic Radiopharmaceuticals and Contrast Media Industry
The diagnostic radiopharmaceuticals and contrast media market is moderately competitive, with a few major players dominating the global market. The presence of major market players, such as Bayer AG, GE Company (GE Healthcare), Cardinal Health Inc., Siemens Healthineers, Bracco Imaging SpA, Curium Pharma, and Guerbet Group, is increasing the overall competitive rivalry of the market. The major players are evolving through strategic alliances such as acquisitions, mergers, partnerships, collaborations, new product launches, and investment in research and development to secure a position in a globally competitive market. For instance, in March 2020, Curium Pharma completed the acquisition of Zevacor Molecular, which is involved in the production of Strontium-82, which is used in the production of Rubidium-82 generators for cardiac PET imaging in the United States.
Diagnostic Radiopharmaceuticals and Contrast Media Market Leaders
-
Cardinal Health Inc.
-
Siemens Healthineers
-
Bracco Imaging SpA
-
GE Company (GE Healthcare)
-
Guerbet Group
*Disclaimer: Major Players sorted in no particular order
